Dosage Frequency: Once daily It is recommended to administer IGF-1 LR3 once daily for six weeks
Treatment recommendations depend on medical history, provider evaluation, laboratory findings, wellness goals, and clinical appropriateness
Cancer promotion concerns arise from IGF-1's well-established role in cellular proliferation, survival, and growth
Cardiovascular Research and GHRP-6 Safety Signals GHRP-6 research in cardiovascular models has documented both potentially beneficial and potentially concerning hemodynamic effects
Studied for effects on lean mass, adipose tissue, and metabolic rate in research models
Petersburg, we believe in creating customized longevity wellness treatment plans that integrate the latest scientific understanding with your individual health profile